Jacob Chacko Oric Pharmaceuticals, Inc. (ORIC) insider trading activity

Jacob Chacko is PRESIDENT AND CEO of Oric Pharmaceuticals, Inc.. Currently has a direct ownership of 778,648 shares of ORIC, which is worth approximately $6.39 Million. The most recent transaction as insider was on May 27, 2021, when has been sold 400 shares (Common Stock) at a price of $25.07 per share, resulting in proceeds of $10,028. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 779K

6.88% 3M change

3.7% 12M change

Total Value Held $6.39 Million

Jacob Chacko Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 27 2021	SELL Open market or private sale	$10,028 $25.07 p/Share	400 Reduced 1.73%	22,732 Common Stock
May 24 2021	SELL Open market or private sale	$300 $25.0 p/Share	12 Reduced 0.05%	23,132 Common Stock
May 21 2021	SELL Open market or private sale	$120,708 $25.2 p/Share	4,790 Reduced 17.15%	23,144 Common Stock
May 20 2021	SELL Open market or private sale	$61,873 $25.07 p/Share	2,468 Reduced 8.12%	27,934 Common Stock
May 18 2021	SELL Open market or private sale	$291,232 $25.7 p/Share	11,332 Reduced 27.15%	30,402 Common Stock
May 17 2021	SELL Open market or private sale	$63,877 $25.05 p/Share	2,550 Reduced 5.76%	41,734 Common Stock
May 14 2021	SELL Open market or private sale	$352,403 $25.36 p/Share	13,896 Reduced 23.88%	44,284 Common Stock
May 13 2021	SELL Open market or private sale	$18,279 $25.04 p/Share	730 Reduced 1.24%	58,180 Common Stock
May 12 2021	SELL Open market or private sale	$10,008 $25.02 p/Share	400 Reduced 0.67%	58,910 Common Stock
May 11 2021	SELL Open market or private sale	$27,490 $25.22 p/Share	1,090 Reduced 1.8%	59,310 Common Stock
Apr 30 2021	SELL Open market or private sale	$15,144 $25.24 p/Share	600 Reduced 0.98%	60,400 Common Stock
Apr 28 2021	SELL Open market or private sale	$17,542 $25.06 p/Share	700 Reduced 1.13%	61,000 Common Stock
Apr 01 2021	SELL Open market or private sale	$20,072 $25.09 p/Share	800 Reduced 1.28%	61,700 Common Stock

Also insider at

TPTX

Turning Point Therapeutics, Inc.

Director

FDMT

4D Molecular Therapeutics, Inc. Healthcare

Jacob Chacko

PRESIDENT AND CEO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORIC shares.

Notify only if

Value

Insider Trading

Get notified when an Oric Pharmaceuticals, Inc. insider buys or sells ORIC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Oric Pharmaceuticals, Inc.

Track Activities on ORIC

Account